IQ-AI Ltd.

  • Market Cap: N/A
  • Industry: Software Products
  • ISIN: JE00BD4H0R42
GBP
0.01
0 (-13.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Software Products

stock-summary
Market cap

GBP 2 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.07

stock-summary
Return on Equity

-14.24%

stock-summary
Price to Book

2.22

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
38.1%
0%
38.1%
6 Months
8.75%
0%
8.75%
1 Year
-40.0%
0%
-40.0%
2 Years
-76.49%
0%
-76.49%
3 Years
-59.53%
0%
-59.53%
4 Years
-86.08%
0%
-86.08%
5 Years
-91.71%
0%
-91.71%

IQ-AI Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
7.86%
EBIT Growth (5y)
10.80%
EBIT to Interest (avg)
-0.48
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.05
Sales to Capital Employed (avg)
0.55
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.40
EV to EBIT
-1.32
EV to EBITDA
-1.32
EV to Capital Employed
1.32
EV to Sales
1.32
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-14.24%
ROE (Latest)
-14.24%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bullish
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by IQ-AI Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is 20.00% vs 0.00% in Dec 2022",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is -20.00% vs 0.00% in Dec 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.60",
          "val2": "0.50",
          "chgp": "20.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.30",
          "val2": "-0.40",
          "chgp": "25.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.20",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.60",
          "val2": "-0.50",
          "chgp": "-20.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-666.80%",
          "val2": "-934.70%",
          "chgp": "26.79%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'23stock-summary
Dec'23
Dec'22
Change(%)
Net Sales
0.60
0.50
20.00%
Operating Profit (PBDIT) excl Other Income
-0.30
-0.40
25.00%
Interest
0.00
0.00
Exceptional Items
-0.20
0.00
Consolidate Net Profit
-0.60
-0.50
-20.00%
Operating Profit Margin (Excl OI)
-666.80%
-934.70%
26.79%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2023 is 20.00% vs 0.00% in Dec 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2023 is -20.00% vs 0.00% in Dec 2022

stock-summaryCompany CV
About IQ-AI Ltd. stock-summary
stock-summary
IQ-AI Ltd.
Software Products
IQ-AI Limited, formerly Flying Brands Limited, is a Jersey-based medical services and software company. The Company provides health care technology solutions to the artificial intelligence (AI) medical imaging market. Through its subsidiary, StoneChecker Software Ltd, It offers medical imaging software for urolithiasis that analyses and presents stone metrics, including stone size, volume, density, skin to stone distance, and stone architecture through TexRAD analysis within the healthcare information technology (IT) systems. Through its subsidiary, Imaging Biometrics, LLC, It specializes in the design and manufacture of visualization tools, the application of machine learning and AI software solutions, and the development and clinical testing of imaging endpoints and biomarkers. Its portfolio consists of IB Neuro and IB Diffusion that are used in treatment of brain tumors, strokes and pathologies.
Company Coordinates stock-summary
Company Details
La Rue De La Frontiere, Retreat Farm , SAINT HELIER None : JE4 8TQ
Registrar Details